1. Home
  2. Stocks
  3. Marksans Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Marksans Pharma Share Price Marksans Pharma

    Mid Cap
    ₹172.15
    +5 (2.99%)
    28 April, 2024 22:58 BSE: 524404 NSE: MARKSANSISIN: INE750C01026

    Start SIP in Marksans Pharma

    Start SIP

    Marksans Pharma Performance

    Day Range

    • Low 166
    • High 174
    ₹ 172

    52 Week Range

    • Low 71
    • High 186
    ₹ 172
    • Open Price168
    • Previous Close167
    • Volume2110794

    Marksans Pharma Share Price

    • Over 1 Month +14.01%
    • Over 3 Month +17.95%
    • Over 6 Month +66.57%
    • Over 1 Year +112.01%

    Marksans Pharma Key Statistics

    P/E Ratio 24.6
    PEG Ratio 0.5
    Market Cap Cr 7,801
    Price to Book Ratio 4.4
    EPS 2.3
    Dividend 0.3
    Relative Strength Index 60.05
    Money Flow Index 58.25
    MACD Signal 4.47
    Average True Range 7.64
    Marksans Pharma Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 241205182153
    Operating Expenses Qtr Cr 199167155130
    Operating Profit Qtr Cr 42372723
    Depreciation Qtr Cr 8854
    Interest Qtr Cr 0001
    Tax Qtr Cr 913105
    Net Profit Qtr Cr 25314418
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 716
    Operating Expenses Annual Cr 563
    Operating Profit Annual in Cr 92
    Depreciation Cr 17
    Interest Annual Cr 4
    Tax Annual Cr 29
    Net Profit Annual Cr 103
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 52
    Cash from Investing Activity Annual Cr -195
    Cash from Financing Annual Activity Cr 210
    Net Cash Flow Annual Cr 67
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,111
    Fixed Assets Annual Cr 148
    Total Non Current Assets Annual Cr 431
    Total Current Assets Annual Cr 914
    Total Assets Annual Cr 1,345
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 25
    ROE Annual % 9
    ROCE Annual % 12
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 23
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 586531500486
    Operating Expenses Qtr Cr 453417398376
    Operating Profit Qtr Cr 133114102110
    Depreciation Qtr Cr 22181414
    Interest Qtr Cr 3222
    Tax Qtr Cr 30302621
    Net Profit Qtr Cr 83846982
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,911
    Operating Expenses Annual Cr 1,513
    Operating Profit Annual in Cr 339
    Depreciation Cr 52
    Interest Annual Cr 9
    Tax Annual Cr 72
    Net Profit Annual Cr 266
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 237
    Cash from Investing Activity Annual Cr -259
    Cash from Financing Annual Activity Cr 198
    Net Cash Flow Annual Cr 176
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,745
    Fixed Assets Annual Cr 458
    Total Non Current Assets Annual Cr 515
    Total Current Assets Annual Cr 1,675
    Total Assets Annual Cr 2,190
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 39
    ROE Annual % 15
    ROCE Annual % 19
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 22
    Sign Up to Know More
    Invest in Marksans Pharma

    Marksans Pharma Technicals

    EMA & SMA

    Current Price
    ₹172.15
    +5 (2.99%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹164.10
    • 50 Day
    • ₹158.42
    • 100 Day
    • ₹151.73
    • 200 Day
    • ₹136.15
    • 20 Day
    • ₹164.12
    • 50 Day
    • ₹156.63
    • 100 Day
    • ₹157.68
    • 200 Day
    • ₹135.75

    Marksans Pharma Resistance and Support

    PIVOT
    ₹170.7
    Resistance
    First Resistance 175.25
    Second Resistance 178.35
    Third Resistance 182.90
    RSI 60.05
    MFI 58.25
    MACD Single Line 4.47
    MACD 4.84
    Support
    First Resistance 167.60
    Second Resistance 163.05
    Third Resistance 159.95

    Marksans Pharma Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,293,241 83,565,702 36.44
    Week 2,073,999 80,616,326 38.87
    1 Month 3,763,676 173,129,081 46
    6 Month 2,939,636 121,142,392 41.21

    Marksans Pharma Result Highlights

    Marksans Pharma Synopsis

    Market Cap
    Sales
    Shares in Float
    No of funds
    Yield
    Book Value
    U/D Vol ratio
    LTDebt / Equity
    Alpha
    Beta

    Marksans Pharma

    Owner Name

    Marksans Pharma Management

    Name Designation

    Marksans Pharma Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Marksans Pharma Corporate Action

    Date Purpose Remarks
    2024-02-13 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-11 Quarterly Results
    2023-05-30 Audited Results & Final Dividend
    2023-02-13 Quarterly Results
    Date Purpose Remarks
    2023-06-07 FINAL Rs.0.50 per share(50%)Final Dividend

    Marksans Pharma MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 17,349
    UTI Aggressive Hybrid Fund Regular Plan Growth 5,306
    UTI Retirement Fund - Regular Plan 4,340
    UTI Large & Mid Cap Fund Regular Plan Growth 2,759
    UTI Healthcare Fund Regular Plan Growth 947

    Marksans Pharma FAQs

    What is Share Price of Marksans Pharma ?

    Marksans Pharma share price is ₹172 As on 28 April, 2024 | 22:44

    What is the Market Cap of Marksans Pharma ?

    The Market Cap of Marksans Pharma is ₹7801.2 Cr As on 28 April, 2024 | 22:44

    What is the P/E ratio of Marksans Pharma ?

    The P/E ratio of Marksans Pharma is 24.6 As on 28 April, 2024 | 22:44

    What is the PB ratio of Marksans Pharma ?

    The PB ratio of Marksans Pharma is 4.4 As on 28 April, 2024 | 22:44

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.